Ancef and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ancef (cefazolin sodium) and Klor-con (potassium chloride). Common drug interactions include gastrooesophageal reflux disease among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ancef and Klor-con. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Ancef?

Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

On Jul, 18, 2026

65 people who take Ancef and Klor-con together, and have interactions are studied.

What are the common drug interactions of Ancef and Klor-Con, by gender? *:

female:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gingival pain (gum pain)
Intervertebral disc degeneration (spinal disc degeneration)
Oedema (fluid collection in tissue)
Osteitis (a general term for inflammation of bone)
Osteoporosis (bones weak and more likely to break)
Oedema peripheral (superficial swelling)
Insomnia (sleeplessness)
Pain in jaw
Vision blurred

male:

Renal failure (kidney dysfunction)
Anxiety
Abdominal pain
Constipation
Headache (pain in head)
Nervousness
Vomiting
Stress
Anaemia (lack of blood)
Fatigue (feeling of tiredness)

What are the common drug interactions of Ancef and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Injury
Pulmonary embolism (blockage of the main artery of the lung)
Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
Cholecystitis chronic (long lasting infection of gallbladder)
Fear of disease
Pain

40-49:

Blood calcium decreased
Blood sodium decreased
Blood urea increased
Enterococcus test positive
Hypoxia (low oxygen in tissues)
Intestinal obstruction
Pericardial effusion (fluid around the heart)
Pleural effusion (water on the lungs)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

50-59:

Anxiety
Arthralgia (joint pain)
Bladder cyst
Bone disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)
Cough
Cystitis (inflammation of the wall of the bladder)
Depression
Diarrhoea

60+:

Pain
Anxiety
Stress
Cardiac failure congestive
Cardiac tamponade (fluid accumulates in heart covering)
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Nausea (feeling of having an urge to vomit)
Pericardial haemorrhage (bleeding into the heart)
Death

What are the existing conditions these people have? *

Pain: 28 people, 43.08%
Stress And Anxiety: 16 people, 24.62%
Neoplasm Malignant (cancer tumour): 16 people, 24.62%
Depression: 16 people, 24.62%
Metastatic Neoplasm (spreadable cancer tumour): 13 people, 20.00%
Hypersensitivity: 13 people, 20.00%
Breast Cancer Metastatic: 13 people, 20.00%
Diabetes: 12 people, 18.46%
High Blood Pressure: 6 people, 9.23%
Insomnia (sleeplessness): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Ancef and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously